Retatrutide achieves superior weight loss as monotherapy with up to 24% body weight reduction, while Cagrilintide achieves 10.8% weight loss alone but can reach over 20% when combined with semaglutide
Get personalized care from anywhere with or without insurance
Preclinical studies suggest that GLP-1 receptor activation in the mesolimbic dopamine system appears to modulate dopamine signaling, which is central to the rewarding effects of alcohol and other addictive substances

increasingly used for moderate-to-severe CD Antibiotics: Metronidazole, ciprofloxacin for perianal disease, fistulae, abscesses Coding Impact of Biologic Therapy When a patient is receiving biologic therapy for Crohns disease, coders should verify: HCPCS code for the specific biologic agent (J1745, J3357, J3380, J7999) is separately reported for the infusion encounter Infusion administration code (CPT 96413, 96415) is reported with the biologic J-code Long-term use of immunosuppressants should be captured with Z79.899 (long-term use of other medication) when relevant Biologic use combined with Crohns disease supports HCC 35 mapping and higher risk scores When corticosteroid use (prednisone, budesonide) extends beyond 90 days, assign Z79.52 (long-term use of systemic steroids)
few patients (9%) were exposed to treatment with dulaglutide for beyond 52 weeks